Table 5.
Biomarker | P value for test of effect | |||
---|---|---|---|---|
Baseline | Time | Treatment | Time × treatment | |
VEGF‐A | <0.001 | 0.941 | <0.001 | 0.032 |
VEGF‐D | <0.001 | <0.001 | <0.001 | <0.001 |
sVEGFR1 | <0.001 | 0.997 | 0.484 | 0.218 |
sVEGFR2 | <0.001 | 0.059 | 0.027 | 0.015 |
COL‐IV | <0.001 | 0.011 | <0.001 | <0.001 |
PLGF | <0.001 | 0.014 | 0.713 | 0.966 |
c‐Kit | <0.001 | 0.089 | 0.414 | 0.022 |
COL‐IV, collagen type IV; PLGF, placental growth factor; VEGF‐A, vascular endothelial growth factor A; VEGF‐D, vascular endothelial growth factor D; sVEGFR1, soluble VEGF receptor 1; sVEGFR2, soluble VEGF receptor 2.